Publication | Open Access
Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial
35
Citations
16
References
2019
Year
More favorable risk factor status and low-dose rivaroxaban were independently associated with lower risk of cardiovascular events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1